As at Sep 28, 2023, the MRK stock has a PE ratio of 85.49. This is based on the current EPS of $1.22 and the stock price of $104.3 per share. An increase of 130% has been recorded in the PE ratio compared to the average of 37.2 of the last four quarters.
The mean historical PE ratio of Merck over the last ten years is 33.95. The current 85.49 P/E ratio is 152% higher than the historical average. In the past ten years, MRK's PE ratio peaked in the Jun 2018 quarter at 119.02, with a price of $60.7 and an EPS of $0.51. The Sep 2015 quarter marked the lowest point at 13.1, with a price of $49.39 and an EPS of $3.77.
Maximum annual increase: 142.6% in 2015
Maximum annual decrease: -58.98% in 2014
| Year | PE ratio | Change |
|---|---|---|
| 2022 | 19.36 | 30.37% |
| 2021 | 14.85 | -49.35% |
| 2020 | 29.32 | 23.82% |
| 2019 | 23.68 | -27.47% |
| 2018 | 32.65 | -48.94% |
| 2017 | 63.94 | 54.22% |
| 2016 | 41.46 | 24.02% |
| 2015 | 33.43 | 142.6% |
| 2014 | 13.78 | -58.98% |
| 2013 | 33.59 | 66.53% |
The current PE ratio of MRK is above the 3, 5 and 10-year averages.
MRK's PE ratio stands higher than its peer stocks LLY and JNJ. Merck is presently trading at a higher PE ratio (85.49) than its peer group average of 30.36.
| Stock name | PE ratio | Market cap |
|---|---|---|
| PFE Pfizer Inc | 8.61 | $185.22B |
| BMY Bristol Myers Squibb Co | 15.39 | $121.51B |
| AMGN Amgen Inc | 18.01 | $143.83B |
| JNJ Johnson & Johnson | 31.24 | $405.13B |
| ABT Abbott Laboratories | 32.95 | $168.69B |
| LLY ELI LILLY & Co | 74.06 | $506.91B |
| MRK Merck & Co Inc | 84.5 | $261.59B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $11.51B |
As of Sep 28, 2023, MRK stock has a price to earnings ratio of 85.49.
The average PE ratio for MRK stock over the past 3 years is 27.44.
The average PE ratio for MRK stock over the past 5 years is 27.63.
Over the last ten years, the quarterly PE ratio reached a historic high of 119.02 in the Jun 2018 quarter.
MRK's current price to earnings ratio is 152% above its 10-year historical average.
MRK's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Sep 28, 2023), Merck's stock price is $104.3. The earnings per share for the trailing twelve months (TTM) ending Jun 2023 is $1.22. Therefore, Merck's PE ratio for today is 85.49. PE RATIO(85.49) = STOCK PRICE($104.3) / TTM EPS($1.22)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.